“It's all about risks and benefits," one researcher said. "Starting transitioning is a big part of a person's life and helping them feel more themselves, but hormone replacement therapy also has a lot of side effects—it's not a risk-free endeavor."

CMS first announced the change late last year via the 2023 Outpatient Prospective Payment System/Ambulatory Surgical Center Final Rule. 

According to a new analysis of data from nearly six million patients, experiencing long-lasting COVID-19 symptoms more than doubles the risk of cardiac complications. 

The CEO of Cardiovascular Associates of America, and former CEO of the American College of Cardiology, shared his perspective on the rise of private equity investments in cardiology. 

Issued by the Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the European Association of Nuclear Medicine (EANM), the new guidelines are intended to inform any practitioners involved in ordering, performing, reading and reporting SSTR PET imaging.

The document, which was designed to help guide both interventional cardiology trainees and program directors, was also endorsed by several other industry societies. 

When long-term continuous monitoring detects bradyarrhythmia in an asymptomatic patient, is it still providing value? 

Some SGLT2 inhibitors have been linked to significant improvements in HF outcomes, but what about sotagliflozin? We spoke with Bertram Pitt, MD, to learn more.